James E Sharman, Eoin O'Brien, Bruce Alpert, Aletta E Schutte, Christian Delles, Michael Hecht Olsen, Roland Asmar, Neil Atkins, Eduardo Barbosa, David Calhoun, Norm R C Campbell, John Chalmers, Ivor Benjamin, Garry Jennings, Stéphane Laurent, Pierre Boutouyrie, Patricio Lopez-Jaramillo, Richard J McManus, Anastasia S Mihailidou, Pedro Ordunez, Raj Padwal, Paolo Palatini, Gianfranco Parati, Neil Poulter, Michael K Rakotz, Clive Rosendorff, Francesca Saladini, Angelo Scuteri, Weimar Sebba Barroso, Myeong-Chan Cho, Ki-Chul Sung, Raymond R Townsend, Ji-Guang Wang, Tine Willum Hansen, Gregory Wozniak, George Stergiou
The Lancet Commission on Hypertension identified that a key action to address the worldwide burden of high blood pressure (BP) was to improve the quality of BP measurements by using BP devices that have been validated for accuracy. Currently, there are over 3 000 commercially available BP devices, but many do not have published data on accuracy testing according to established scientific standards. This problem is enabled through weak or absent regulations that allow clearance of devices for commercial use without formal validation...
2020: Pan American Journal of Public Health